{"url_path":"/sec/mrkr/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1094038/0001104659-26-062763-index.html","accession_number":"0001104659-26-062763","cik":"0001094038","ticker":"MRKR","issuer_name":"Marker Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1094038/0001104659-26-062763-index.html","primary_entity_key":"0001094038","primary_entity_name":"Marker Therapeutics, Inc."},"word_count":28,"has_tables":true,"body_markdown":"**Item 2.         Unregistered Sales of Equity Securities and Use of Proceeds**\n\nWe did not record any issuances of unregistered securities during the three months ended March 31, 2026."}